Ethambutol Hydrochloride/Isoniazid/Pyrazinamide/Rifampicin

盐酸乙胺丁醇/异烟肼/吡嗪酰胺/利福平

Report date: 2023/04/13 17:55:47

Base Information

Drug NameEthambutol Hydrochloride/Isoniazid/Pyrazinamide/Rifampicin
Drug Alias Name乙胺丁醇盐酸盐异烟肼吡嗪酰胺利福平Rifampicin/Isoniazid/Pyrazinamide/Ethambutol乙胺吡嗪利福异烟Ethambutol and Isoniazid and Pyrazinamide and RifampicinRimstar
ClassificationSmall molecules
Mechanisms of ActionFatty acid synthase inhibitorsBacterial DNA-directed RNA polymerase inhibitorsDNA-directed RNA polymerase beta chain inhibitors
TargetsFatty acid synthaseBacterial DNA-directed RNA polymeraseDNA-directed RNA polymerase beta chain
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsTuberculosis, Pulmonary
Approved Indications in ChinaTuberculosis, Pulmonary
Original Approved Country/TerritoryDenmark
Original Approved Date2003/03/06
Country/TerritoryDenmarkMainland China
CombinationsYes Ethambutol HydrochlorideRifampicinIsoniazid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgShenyang Hongqi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeJ04AM06
Related LinksWikipedia